Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: Investors sell themselves short by trading too often.
Plus: SoftBank takes an Intel stake as the US government looms.
Plus: Advisors doubt AI will replace them anytime soon.
Plus: Novo Nordisk soars after slashing Ozempic prices.
Plus: Upskilling Without the Headache; Walmart’s Logistics Transformation
Plus: Waymo and Tesla want to bring robotaxis to New York.
Are cyclical funds in season?
Can the social media also-ran succeed in the era of AI?